INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
Corporate insider
PK

Parikh Anand Kiran

Director, Chief Operating OfficerCIK 0002111813

EDGAR filingsOpen in network
Disclosed transactions13
Buys / sells1 / 0
Max Insider Score37
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
8
PK
Parikh Anand KiranDirector, President and CEO
FTHFaeth Therapeutics, Inc.
Gift
G—
100.0K sh
Oct 30, 2026Nov 3, 2026
traded Oct 30, 2026
+4dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Faeth Therapeutics, Inc.Director, Chief Operating Officer · Feb 19, 2026
12
PK
Parikh Anand KiranDirector, President and CEO
FTHFaeth Therapeutics, Inc.
Gift
G
—
100.0K sh
Oct 30, 2026
Nov 3, 2026
traded Oct 30, 2026
+4d
SEC FORM 4

Evidence

9
PK
Parikh Anand KiranDirector, President and CEO
FTHFaeth Therapeutics, Inc.
Option exercise
M$9,527
8,213 sh
Jun 22, 2026Jun 24, 2026
traded Jun 22, 2026
+2dSEC FORM 4

Evidence

21
PK
Parikh Anand KiranDirector, President and CEO
FTHFaeth Therapeutics, Inc.
Option exercise
M—
45.3K sh
Jun 22, 2026Jun 24, 2026
traded Jun 22, 2026
+2dSEC FORM 4

Evidence

9
PK
Parikh Anand KiranDirector, President and CEO
FTHFaeth Therapeutics, Inc.
Option exercise
M—
8,213 sh
Jun 22, 2026Jun 24, 2026
traded Jun 22, 2026
+2dSEC FORM 4

Evidence

16
PK
Parikh Anand KiranDirector, President and CEO
FTHFaeth Therapeutics, Inc.
Option exercise
M$52K
45.3K sh
Jun 22, 2026Jun 24, 2026
traded Jun 22, 2026
+2dSEC FORM 4

Evidence

37
PK
Parikh Anand KiranDirector, President and CEO
FTHFaeth Therapeutics, Inc.
Open-market purchase
BUY$55K
2,806 sh
Jun 22, 2026Jun 24, 2026
traded Jun 22, 2026
+2dSEC FORM 4

Evidence

9
PK
Parikh Anand KiranDirector, President and CEO
FTHFaeth Therapeutics, Inc.
Derivative conversion
C—
761.4K sh
Jun 15, 2026Jun 16, 2026
traded Jun 15, 2026
+1dSEC FORM 4

Evidence

9
PK
Parikh Anand KiranDirector, President and CEO
FTHFaeth Therapeutics, Inc.
Derivative conversion
C—
761 sh
Jun 15, 2026Jun 16, 2026
traded Jun 15, 2026
+1dSEC FORM 4

Evidence

9
PK
Parikh Anand KiranDirector, Chief Operating Officer
SNSEFaeth Therapeutics, Inc.
Grant or award
A—
809.8K sh
Feb 17, 2026Feb 19, 2026
traded Feb 17, 2026
+2dSEC FORM 4

Evidence

9
PK
Parikh Anand KiranDirector, Chief Operating Officer
SNSEFaeth Therapeutics, Inc.
Grant or award
A—
92.5K sh
Feb 17, 2026Feb 19, 2026
traded Feb 17, 2026
+2dSEC FORM 4

Evidence

9
PK
Parikh Anand KiranDirector, Chief Operating Officer
SNSEFaeth Therapeutics, Inc.
Grant or award
A—
56.7K sh
Feb 17, 2026Feb 19, 2026
traded Feb 17, 2026
+2dSEC FORM 4

Evidence

9
PK
Parikh Anand KiranDirector, Chief Operating Officer
SNSEFaeth Therapeutics, Inc.
Grant or award
A—
1.24M sh
Feb 19, 2026Feb 19, 2026
traded Feb 19, 2026
+0dSEC FORM 4

Evidence